Browsing: vaccine gap

Moderna has begun testing a new vaccine candidate in Phase 1 for Bundibugyo ebolavirus in Canada. The initial participant received the mRNA-1469 vaccine on August 3 at a site in Truro, Nova Scotia. This trial launches at a time when the virus continues to spread across multiple provinces in the Democratic Republic of the Congo. The World Health Organization has designated the situation as a public health emergency of international concern.